Anika Therapeutics reported $1.24M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 2366M 678M
Acceleron Pharma XLRN:US $ -62.63M 0.05M
Agenus AGEN:US $ -64.67M 25.03M
Agios Pharmaceuticals AGIO:US $ -88.87M 0.13M
Anika Therapeutics ANIK:US $ 1.24M 1.28M
Arrowhead Research ARWR:US $ -29868000 3.56M
Chemocentryx CCXI:US $ -37.74M 8.52M
Dicerna Pharmaceuticals DRNA:US $ -38.58M 10.29M
Flexion Therapeutics FLXN:US $ -16357000 6.26M
Halozyme Therapeutics HALO:US $ 93.85M 42.37M
Heron Therapeutics HRTX:US $ -59.74M 8.36M
Immunogen IMGN:US $ -26.83M 1.54M
Insmed INSM:US $ -84649000 4.74M
Integra Lifesciences IART:US $ 84.86M 2.26M
Johnson & Johnson JNJ:US $ 8103M 786M
Karyopharm Therapeutics KPTI:US $ -48819000 3.32M
Ligand Pharmaceuticals LGND:US $ 57.54M 40.26M
Macrogenics MGNX:US $ -37498000 11.07M
Merit Medical Systems MMSI:US $ 39.03M 3.44M
Peregrine Pharmaceuticals PPHM:US $ 7.94M 3.85M
Rigel Pharmaceuticals RIGL:US $ -12.79M 54.78M
Sangamo Biosciences SGMO:US $ -46.46M 2.03M
Stryker SYK:US $ 1084M 218M
Surmodics SRDX:US $ -0.08M 11.47M
Veracyte VCYT:US $ 5.73M 13.49M
Xencor XNCR:US $ 10.84M 24.87M
Zimmer Biomet Holdings Inc ZBH:US $ 569M 22.2M